IE 11 is a very old Browser and it`s not supported on this site

6. Proposal of the Board of Directors for the appropriation of retained earnings 

in CHF

2023 Proposal of the Board

2022 Resolution passed at the AGM

Retained earnings at the disposal of the Annual General Meeting

919 317 855

918 922 082

Dividend

(110 800 000)

(156 311 100)

Carry forward to the next period

808 517 855

762 610 982

919 317 855

918 922 082

BB Biotech AG uses cookies to improve website usability and ensure the best possible user experience. Use of cookies & disclaimer